Sanavo
About Sanavo
This startup develops nanogels that deliver therapeutic agents across the blood-brain barrier, releasing them directly at glioblastoma tumor sites while degrading into harmless sugar. By utilizing FDA-approved materials, the technology aims to transform glioblastoma from a terminal diagnosis into a manageable condition, potentially saving over 200,000 lives annually.
What does Sanavo do?
This startup develops nanogels that deliver therapeutic agents across the blood-brain barrier, releasing them directly at glioblastoma tumor sites while degrading into harmless sugar. By utilizing FDA-approved materials, the technology aims to transform glioblastoma from a terminal diagnosis into a manageable condition, potentially saving over 200,000 lives annually.
Where is Sanavo located?
Sanavo is based in Cambridge, United Kingdom.
When was Sanavo founded?
Sanavo was founded in 2024.
- Location
- Cambridge, United Kingdom
- Founded
- 2024
- Employees
- 2 employees